Rodrigo Zanolo will start a new role as GenoMar's commercial director on November 7.

Tilapia breeder hires new commercial chief

Zanolo has excellent understanding and knowledge of customers and markets, says GenoMar

Published

Tilapia breeding company GenoMar Genetics Group has announced the appointment of Rodrigo Zanolo as commercial director.

Based in Brazil, he will take responsibility over the commercial activities of the group in Latin America and Asia, including sales, marketing, customer and technical services.

Zanolo comes from MSD Animal Health where he held several commercial and technical leadership positions with a strong record of commercialising technology products in the tilapia value chain. He is a veterinarian (DVM) and holds a Master of Animal Science and two Master of Business and Administrations (MBAs) in Marketing and Leadership respectively.

GenoMar chief executive Alejandro Tola said: “We’re delighted to welcome Rodrigo to our team. He is a well-known and committed professional within the tilapia community, and his 16 years’ industry experience means he has an excellent understanding and knowledge of our customers and the markets we operate in.”

Scientific know-how

Zanolo said he looked forward to working with GenoMar’s commercial teams in Brazil and around the world to bring the company's portfolio of brands and products to more customers and segments in the market.

“I believe that GenoMar’s scientific know-how, constant product development and long-term commitment to the industry will continue to make important contributions to the sustainability and economic performance of the Brazilian and global tilapia farming industry as it has done for the past 30 years,” he added.

“Genetic improvement is that critical tool that will be taking our industry to a new level of performance today and in the future.”

Zanolo begins his new role on November 7 and will be based at GenoMar’s offices in Londrina, Brazil.

GenoMar is a subsidiary of German poultry and aquaculture breeding specialist EW Group, which also owns Norway and Scotland salmon breeder AquaGen.